Divis Laboratories has target of Rs 1050 in the next 12-18 months, says PN Vijay, Portfolio Manager.
Vijay told CNBC-TV18, "Divis Laboratories used to be buzzing stock but it fell off. In the last quarter they came in with profit with revenue growth of about more than 40% and profit growth of about 45% which in these tough days is very good indeed."
He further added, "Divis is a midcap pharma company, it
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!